Cardiomyopathy and hypoxia
Moret, P.R.
Recent Advances in Studies on Cardiac Structure and Metabolism 2: 559-566
1973
ISSN/ISBN: 0363-5872 PMID: 4806987 Document Number: 70060
Document emailed within 1 workday
Related Documents
Smith, F.; Lee, R.; Haindl, W. 1989: Hypoxic cardiomyopathy: acute myocardial dysfunction after severe hypoxia Australian and New Zealand Journal of Medicine 19(5): 488-492Bianciardi, P.; Fantacci, M.; Caretti, A.; Ronchi, R.; Milano, G.; Morel, S.; von Segesser, L.; Corno, A.; Samaja, M. 2006: Chronic in vivo hypoxia in various organs: hypoxia-inducible factor-1alpha and apoptosis Biochemical and Biophysical Research Communications 342(3): 875-880
Seifeddine, R.; Fulchignoni-Lataud, M.-C.; Massaad-Massade, L. 2009: Down-regulation of C/EBPalpha in breast cancer cells by hypoxia-estrogen combination is mainly due to hypoxia Anticancer Research 29(4): 1227-1231
Bhatia, B.; Subramanian, R. 1974: Changes in resistance to hypoxia following single short-term exposures to hypoxia Indian Journal of Medical Research 62(12): 1928-1936
Papadopoulou, M.V.; Ji, M.; Bloomer, W.D. 2006: Novel fluorinated hypoxia-targeted compounds as Non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS) Anticancer Research 26(5a): 3253-3258
Raleigh, J.A.; Calkins-Adams, D.P.; Rinker, L.H.; Ballenger, C.A.; Weissler, M.C.; Fowler, W.C.; Novotny, D.B.; Varia, M.A. 1998: Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker Cancer Research 58(17): 3765-3768
Wu, X.-A.; Sun, Y.; Fan, Q.-X.; Wang, L.-X.; Wang, R.-L.; Zhang, L. 2007: Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia Zhonghua Yi Xue Za Zhi 87(37): 2640-2644
Ferguson JE, I.I.; Harney, K.S.; Bachicha, J.A. 1986: Peripartum maternal cardiomyopathy with idiopathic cardiomyopathy in the offspring. A case report Journal of Reproductive Medicine 31(12): 1109-1112
Shaposhnik, I.I.; Shaposhnik, O.D. 1992: The development of signs of dilated cardiomyopathy in patients with nonobstructive hypertrophic cardiomyopathy Terapevticheskii Arkhiv 64(11): 125-126
Thies, W.R.; Vyska, K.; Matthies, W.; Notohamiprodjo, G.; Knapp, W.; Meyer, H. 1989: Changes in fatty acid metabolism in dilated cardiomyopathy and hypertrophic cardiomyopathy in childhood Wiener Klinische Wochenschrift 101(1): 8-11
Cecchi, F.; Olivotto, I.; Lazzeroni, E.; Chiriatti, G.; Sachero, A.; Beretta, L.; Giagnoni, E.; Renosto, G.; Montereggi, A.; Baldassarre, S.; Castelli, G.; Ciaccheri, M. 1997: Clinical course of hypertrophic cardiomyopathy in a non selected population. the Experience of the Italian Multicenter Cardiomyopathy Study Giornale Italiano di Cardiologia 27(11): 1133-1143
Masuda, Y. 2000: Differential diagnosis of idiopathic cardiomyopathy from ischemic cardiomyopathy and hypertensive heart disease using non-invasive methods Nihon Rinsho. Japanese Journal of Clinical Medicine 58(1): 218-222
Lin, Y.T.; Wu, M.H.; Wang, J.K.; Lue, H.C. 1998: Evolution of dilated cardiomyopathy from hypertrophic obstructive cardiomyopathy in a child Journal of the Formosan Medical Association 97(6): 416-419
Kuburović, V.; Vukomanović, V.; Kosutić, J.; Rakić, S.; Kuburović, N. 2010: An unusual presentation of cardiomyopathy in a patient with microcephaly-cardiomyopathy syndrome Turkish Journal of Pediatrics 52(1): 85-88
Tian, Y.; Liu, X.; Shi, R.; Liu, Y.; Wu, Q.; Zhang, X. 2000: Radionuclide techniques for evaluating dilated cardiomyopathy and ischemic cardiomyopathy Chinese Medical Journal 113(5): 392-395
Waśniewska, M.; Pacocha, W.; Kapuściński, O. 1976: Clinical manifestations, hemodynamic disorders and radiographic changes in primary cardiomyopathy. I. Hypertrophic cardiomyopathy with stenosis of the left ventricular outflow Kardiologia Polska 19(1): 33-38
Kaluz, S.; Kaluzová, M.; Chrastina, A.; Olive, P.L.; Pastoreková, S.; Pastorek, J.ír.; Lerman, M.I.; Stanbridge, E.J. 2002: Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase Cancer Research 62(15): 4469-4477
Zhang, X.-y.; Wang, X.; Sun, S.-z.; Song, Y.; Yang, M.-x.; Qu, X. 2007: Effect of hypoxia inducible factor-1 alpha on vascular endothelial growth factor expression in human tongue squamous carcinoma cells (Tca8113) under hypoxia Zhonghua Kou Qiang Yi Xue Za Zhi 42(12): 747-749
Coughlin, S.S.; Myers, L.; Michaels, R.K. 1997: What explains black-white differences in survival in idiopathic dilated cardiomyopathy? the Washington, DC, Dilated Cardiomyopathy Study Journal of the National Medical Association 89(4): 277-282
Menzel, K.; Buchenau, W.; Wiedemann, G.; Bernklau, P.; Radam, M.; Töpke, B.; Artjuschenko, T.; Thomas, A. 1984: Animal experiments on the behavior of selected criteria for hypoxia (serum lactate, glucose, hypoxanthine and creatine kinase, acid-base balance) in the arterial and venous blood of the skull in newborn piglets following experimental normobaric hypoxia Kinderarztliche Praxis 52(5): 223-231